A new equine pericardial stentless valve.

Area of Science:

• Cardiovascular Surgery
• Biomedical Engineering
• Prosthetic Heart Valves

Background:

• Small aortic valve replacement presents significant hemodynamic challenges.
• Existing stentless bioprostheses offer improvements but have limitations.
• A new bioprosthesis design aims to optimize hemodynamic performance.

Purpose of the Study:

• To evaluate the hemodynamic performance of a novel equine pericardial bioprosthesis.
• To compare the new bioprosthesis against a commercially available stentless prosthesis.
• To assess performance in a bovine model for aortic valve replacement.

Main Methods:

• Twelve calves underwent implantation of either the new 3F bioprosthesis (n=6) or a control stentless valve (n=6).
• Hemodynamic monitoring and transvalvular gradient measurements were performed.
• Dopamine infusion was used to assess valve function under increasing physiological load.

Main Results:

• The 3F bioprosthesis group exhibited significantly lower mean transvalvular gradients at 4.5 L/min (3.48 vs 5.72 mm Hg) and 6.5 L/min (7.4 vs 11.13 mm Hg) compared to controls (P <.0001).
• Effective orifice area was significantly larger for the 3F bioprosthesis at both flow rates (2.4 vs 1.86 cm² at 4.5 L/min; 2.41 vs 1.96 cm² at 6.5 L/min) (P <.0001).
• These findings indicate superior hemodynamic efficiency of the novel bioprosthesis.

Conclusions:

• The novel stentless bioprosthesis, featuring a unique design with commissures fixed directly to the aorta, demonstrates superior in vivo hemodynamic performance.
• It outperforms standard stentless prostheses in the immediate post-implantation period.
• This new valve represents a promising advancement for small aortic valve replacement.